ROS‐Sensitive Hydrogel With Methotrexate‐ss‐Oxidized Bletilla striata Polysaccharide Nanoparticles for the Enhanced Treatment of Rheumatoid Arthritis
Advanced Healthcare Materials · 2026
DOI: 10.1002/adhm.71627 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Healthcare Materials, 2026. Verfasst von Rui Ma und 6 weiteren Autor:innen. Beteiligte Einrichtung: College of Pharmacy, Qiqihar Medical University, Qiqihar, China. Hauptthemen laut MEDLINE: Nanoparticles, Arthritis, Rheumatoid, Polysaccharides, Methotrexate. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 46 Literaturangaben. Gefördert von: Heilongjiang Provincial Natural Science Foundation of China, Construction Project of Dominant Characteristic Disciplines of Qiqihar Medical University.
Abstract (Originalsprache)
Remodeling the immune microenvironment and scavenging excess reactive oxygen species (ROS) are considered effective strategies for treating rheumatoid arthritis (RA). Methotrexate (MTX), a first‐line drug, can correct the imbalance between helper T‐cell type 17 and regulatory T cells (Th17/Treg) and inhibit the proliferation and migration of fibroblast‐like synoviocytes (FLSs). However, it lacks antioxidant and macrophage regulatory functions, is prone to systemic toxicity, and has poor solubility. In this study, MTX and oxidized Bletilla striata polysaccharide (OBSP) were conjugated and self‐assembled into MTX‐ss‐OBSP NPs via disulfide bonds to integrate macrophage‐polarizing and antioxidant activities. These nanoparticles were loaded into a novel ROS‐responsive oxidized hyaluronic acid‐3‐aminophenylboronic acid–hyaluronic acid (OHA‐PBA‐HA) hydrogel, yielding MTX‐ss‐OBSP NPs@OHA‐PBA‐HA. This injectable hydrogel exhibits ROS‐triggered drug release, reduces ROS levels, promotes M2 macrophage polarization, and modulates cytokine secretion (decreasing IL‐6/TNF‐α; increasing IL‐10). In vivo experiments demonstrated that the hydrogel blocks bone erosion, inhibits synovial inflammation, protects cartilage, and regulates M1/M2 and Th17/Treg balances while significantly reducing MTX‐induced hepatotoxicity and nephrotoxicity. Compared with free MTX, this nanoparticle‐loaded hydrogel accelerates the resolution of RA inflammation with superior safety. Therefore, this responsive hydrogel system represents a promising candidate for clinical RA treatment by integrating immune remodeling and antioxidant therapy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- College of Pharmacy, Qiqihar Medical University, Qiqihar, China.
ORCID-Profile: Tingting Liu, Xiaoyu Sui
Förderung
- Heilongjiang Provincial Natural Science Foundation of China
- Construction Project of Dominant Characteristic Disciplines of Qiqihar Medical University
Zitieren
APA
Ma, R., Yuan, C., Huo, W., Han, C., Ma, X., Liu, T., & Sui, X. (2026). ROS‐Sensitive Hydrogel With Methotrexate‐ss‐Oxidized Bletilla striata Polysaccharide Nanoparticles for the Enhanced Treatment of Rheumatoid Arthritis. Advanced Healthcare Materials. https://doi.org/10.1002/adhm.71627
Vancouver
Ma R, Yuan C, Huo W, Han C, Ma X, Liu T, et al. ROS‐Sensitive Hydrogel With Methotrexate‐ss‐Oxidized Bletilla striata Polysaccharide Nanoparticles for the Enhanced Treatment of Rheumatoid Arthritis. Advanced Healthcare Materials. 2026. doi:10.1002/adhm.71627
BibTeX
@article{Ma2026,
author = {Ma, Rui and Yuan, Cheng and Huo, Wenbo and Han, Cuiyan and Ma, Xiaoxing and Liu, Tingting and Sui, Xiaoyu},
title = {ROS‐Sensitive Hydrogel With Methotrexate‐ss‐Oxidized Bletilla striata Polysaccharide Nanoparticles for the Enhanced Treatment of Rheumatoid Arthritis},
journal = {Advanced Healthcare Materials},
year = {2026},
doi = {10.1002/adhm.71627}
}
EUVIMED